Abstract:Several chemotherapeutic drugs are known to cause significant clinical neurotoxicity, which can result in the early cessation of treatment. To identify and develop more effective means of neuroprotection it is important to understand the toxicity of these drugs at the molecular and cellular levels. This study describes molecular interactions between human brain acetylcholinesterase (AChE) and the well-known anti-neoplastic drug, Cisplatin. Docking between Cisplatin and AChE was performed using 'GOLD 5.0' and accessible surface area of protein before and after ligand binding was calculated by NACCESS version 2.1.1. Hydrophobic interactions and hydrogen bonds both play an equally important role in the correct positioning of Cisplatin within the 'acyl pocket' as well as 'catalytic site' of AChE to permit docking. Gold fitness score of 'Cisplatin-acyl domain of AChE' interaction and 'Cisplatin-CAS domain of AChE' interaction were 38.78 and 39.91, respectively and free binding energy was found to be -5.82 Kcal/ mol and -5.79 Kcal/ mol, respectively. During 'Cisplatin-CAS site of AChE enzyme' interaction, it was found that out of the three amino acids constituting the catalytic triad (S203, H447 and E334), two amino acid residues namely S203 and H447 interact with Cisplatin by hydrogen bonding and hydrophobic interaction, respectively. The values for 'accessible surface area' for the amino acid residues H447 and S203 were found to be reduced by 14.398 angstrom(2) and 3.894 angstrom(2), respectively after interaction with Cisplatin. Hence, Cisplatin might act as a potent inhibitor of AChE. Scope still remains in the determination of the three-dimensional structure of AChE-Cisplatin complex by X-ray crystallography to validate the described data. Moreover, such information may aid in the design of versatile AChE-inhibitors, and is expected to aid in safe clinical use of Cisplatin.

Human Erythrocyte Acetylcholinesterase Inhibition by Cis-Diamminediaquaplatinum (II): a Novel Kinetic Approach

Kinetics of Human Erythrocyte Acetylcholinesterase Inhibition by Cis-Diamminediaquaplatinum (Ii)

Estimation and Correlation of IC50 for the Inhibition of Human Erythrocyte Acetylcholinesterase by Cis-Diamminediaquaplatinum (II).

Characterization of Human Erythrocyte Membrane-Bound Acetylcholinesterase Inhibition by Cisplatin at Reversible Phase.

The Mode of Inhibition of Human Erythrocyte Membrane-Bound Acetylcholinesterase by Cisplatin In-Vitro

Human Platelet Acetylcholinesterase Inhibition by Cyclophosphamide: A Combined Experimental and Computational Approach

Kinetics of the inhibition of acetylcholinesterase in camel retina by cisplatin.

Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.

In Vitro Inhibition of Human Erythrocyte Acetylcholinesterase (EC3.1.1.7) by an Antineoplastic Drug Methotrexate

The Preparation and Kinetic Analysis of Multiple Forms of Human Erythrocyte Acetylcholinesterase

Multiple Approaches to Analyse the Data for Rat Brain Acetylcholinesterase Inhibition by Cyclophosphamide

A neuroinformatics study describing molecular interaction of Cisplatin with acetylcholinesterase: a plausible cause for anticancer drug induced neurotoxicity.

Optimization and Kinetic Studies of Human Erythrocyte Membrane-Bound Acetylcholinesterase

Probing the Interaction Induced Conformation Transitions in Acid Phosphatase with Cobalt Ferrite Nanoparticles: Relation to Inhibition and Bio-Activity of Chlorella Vulgaris Acid Phosphatase.

Kinetics of Human Serum Butyrylcholinesterase Inhibition by a Novel Experimental Alzheimer Therapeutic, Dihydrobenzodioxepine Cymserine

Preconcentration and determination of ultra-traces of platinum in human serum using the combined electrodeposition-electrothermal atomic absorption spectroscopy (ED-ETAAS) and chemometric method

Dual Substrate Model for Novel Approach Towards a Kinetic Study of Acetylcholinesterase Inhibition by Diazinon

Inhibition Kinetic Spectrophotometric Determination Of Platinium

Synthesis, crystal structure, cytotoxicity, in-detail experimental and computational CT-DNA interaction studies of 2-picolinate Pd(II) and Pt(II) complexes

Kinetic Study of Paracetamol on Prolidase Activity in Erythrocytes by Capillary Electrophoresis with Ru(Bpy)(3)(2+) Electrochemiluminescence Detection

Chemical and Cellular Investigations of Trans-Ammine-pyridine-dichlorido-platinum(ii), the Likely Metabolite of the Antitumor Active Cis-Diammine-pyridine-chorido-platinum(ii).